Veterinary Cannabis Society

Just in time for Black Friday, our Veterinary Cannabis Society x Frankie Smoke jewelry line has LAUNCHED! These darling charms are intended for pets and their parents. Because Frankie Smoke donates 40% of the proceeds back to VCS, they're fashionable AND supportive of the veterinary cannabis cause. Instead of funding corporate monopolies this Black Friday, put your money where your pet's mouth is. Purchase a VCS pet charm for yourself and your fur family today! https://lnkd.in/dTURAdQv

We just learned that Bond Vet has a YouTube podcast series, which is exciting! What's more exciting is how we learned: Dr. Trina was featured in one of their episodes! The topic was, of course, veterinary cannabis. The episode is titled "Turning the Alternative Mainstream." And that's precisely what we're trying to do! Be sure to comment on the video so it gets an algorithmic boost. https://lnkd.in/dRmcrZFX

Our Pack Leader Level sponsor, Evermore Pet Food, has won the Good Chicken Award from Compassion in World Farming! The CIWF Good Farm Animal Welfare Awards acknowledges companies that demonstrate a commitment to improving the welfare of their supply chains. The Good Chicken Award acknowledges Evermore’s Better Chicken Commitment (BCC). The award underscores Evermore's place at the forefront of a broader movement, where demand for sustainable and ethically sourced products continues to rise. By setting such high standards for their meat suppliers, Evermore not only enhances the lives of pets but has now surpassed sourcing commitments within the pet food and human food supply chains. We're so proud of Evermore. They're trailblazers in the pet product community. They're awesome people to work with. And their food is downright tasty (according to humans and pets). Congratulations, Hanna and Alison!

Our friends and sponsors Rooted Owl™/ Animal & Plant Sciences just released a clever new CBD + CBG cat and dog treat! These fish-flavored treats are great for picky eaters and pets with protein or chicken sensitivities. We can't wait to test them on our finnicky kitties! (PS: Rooted Owl's pet treats are human grade. So if you're craving fish and serenity, you can technically chow down alongside Fido. Just sayin'.)

'Tis the season! 🎃 It's time for pet parents to slurp up those dumb-delicious Pumpkin Spice Lattes. And pets to gobble up the smart-delicious Earth Buddy Pet CBD treats. Pumpkin season is for the whole family. Woof woof! REMINDER: VCS members receive a special discount on Earth Buddy products! In return, Earth Buddy donates that value back to VCS. Visit the "Opportunities & Events" page of your Members Dashboard to get the code!

Please offer a warm welcome to the newest Veterinary Cannabis Society sponsor, AstraSana Animal Health AG! AstraSana Animal Health is a Swiss company specializing in EU-licensed animal CBD products. With a strong focus on quality, efficacy, and safety, the company develops innovative solutions that set new standards in modern veterinary medicine. Through its international reach, AstraSana brings its expertise in animal health to a global level. You might recognize its Managing Director, Sandra Bruckner. She is a VCS Board Member and one of our European leaders. We’re delighted to have AstraSana Animal Health join our team.

For years there's been discussion amongst veterinarians about the interactions of cannabidiol and non-steroidal anti-inflammatory drugs (NSAIDs). On September 25, the results of a study were published that covered just this topic! Title: Evaluation of the effect of cannabidiol administration with and without nonsteroidal anti-inflammatory drugs in dogs with mobility disorders: a prospective, double-blind, crossover, placebo-controlled study Authors: Bryce Talsma, Lindsay Hochman Elam, Stephanie McGrath, Tianjian Zhou, Craig B. Webb, Felix Michael Duerr (NOTE: Stephanie is an advisor to VCS!) Intro: Introduction: With rapidly growing interest in the use of cannabidiol (CBD) in the management of pain and other conditions, more information is needed on the safety and efficacy of this supplement, particularly its co-administration with commonly used pharmaceuticals such as non-steroidal anti-inflammatory drugs (NSAIDs). This study sought to assess the effect of CBD in dogs with mobility impairments, as well as evaluate the clinical tolerance of CBD used together with NSAIDs. Results: Thirty-eight dogs finished the study with thirty-nine included for at least partial analysis. Compared to baseline, dogs receiving CBD showed evidence of improved outcomes based on blinded veterinary assessments and accelerometer data. Compared to placebo, dogs receiving CBD showed some evidence of improved outcomes on CBPI, CSOM, and blinded veterinary assessments, but not for objective outcome measures. There was evidence of increased ALP when CBD was co-administered with NSAIDs compared to CBD administration alone. Additionally, there was evidence of ALT elevations with CBD and NSAID co-administration, but this elevation did not show evidence of an increase over CBD use alone. You can read the full study on Frontiers in Veterinary Science. What do you think about these results? Will they affect your pets' treatment plans?

So, you've launched a new veterinary cannabis product. It's high-quality, lab-tested, and demonstrated sound observational results. But how can you market it within the FDA's requirements? What happens if you don't? VCS has a workshop for that! Join Jennifer Whetzel, founder of Ladyjane Branding and author of the award-winning Women in Cannabis study, in this essential workshop for members and supporters of the Veterinary Cannabis Society. This course will guide you through the complexities of U.S. regulations on marketing and advertising hemp and CBD products in the veterinary field. With a focus on compliant messaging, Jennifer brings over 25 years of branding expertise and a deep understanding of the cannabis industry's challenges and opportunities. Wednesday, October 30th, 11:00 - 1:00 pm Eastern Time. Reserve your place today: https://lnkd.in/d_qyqSNW

Our Board Member, Dr. Elena Battaglia, is proud to call the authors of this study her colleagues and friends! Even as the Italian government continues to threaten restrictions on cannabis and CBD, Dr. Elena and her colleagues remain dedicated to its study and application. They're veterinary heroes! Title: Pharmacokinetics, efficacy, and safety of cannabidiol in dogs: an update of current knowledge Date: June 2023 Authors: Alessandra Di Salvo, Maria Beatrice Conti, Giorgia della Rocca Summary: "Despite a certain number of available pharmacokinetic studies, the kinetic profile of CBD has yet to be fully known, probably because of the very different experimental conditions. In terms of efficacy, most studies have tested CBD’ ability to relieve osteoarthritic pain. In contrast, few studies have evaluated its role in epilepsy, behavioral disorders, and skin lesions. From obtained results, some evidence exists supporting the beneficial role of CBD. Nevertheless, the limited number of published studies and the occurrence of bias in almost all require caution in interpreting findings. From tolerability studies, CBD’ side effects can be classified as mild or unremarkable. However, studies were prevalently focused on short- to medium-term treatment, while CBD is usually employed for long-term treatment. Further studies are warranted to define better whether CBD could be a valid adjunct in canine treatment." Find the full study in our Curated Research Library and Frontiers in Veterinary Medicine!

Updates to #cannabislaw in #Connecticut. Will this affect your business? Your practice? You or your pet's health? Let us know in the comments!